Literature DB >> 17923669

Self-assembled lamellar complexes of siRNA with lipidic aminoglycoside derivatives promote efficient siRNA delivery and interference.

Léa Desigaux1, Matthieu Sainlos, Olivier Lambert, Raphael Chevre, Emilie Letrou-Bonneval, Jean-Pierre Vigneron, Pierre Lehn, Jean-Marie Lehn, Bruno Pitard.   

Abstract

RNA interference requires efficient delivery of small double-stranded RNA molecules into the target cells and their subsequent incorporation into RNA-induced silencing complexes. Although current cationic lipids commonly used for DNA transfection have also been used for siRNA transfection, a clear need still exists for better siRNA delivery to improve the gene silencing efficiency. We synthesized a series of cationic lipids characterized by head groups bearing various aminoglycosides for specific interaction with RNA. siRNA complexation with such lipidic aminoglycoside derivatives exhibited three lipid/siRNA ratio-dependent domains of colloidal stability. Fluorescence and dynamic light-scattering experiments showed that cationic lipid/siRNA complexes were formed at lower charge ratios, exhibited a reduced zone of colloidal instability, and had smaller mean diameters compared with our previously described guanidinium-based cationic lipids. Cryo-transmission electron microscopy and x-ray-scattering experiments showed that, although the final in toto morphology of the lipid/siRNA complexes depended on the aminoglycoside type, there was a general supramolecular arrangement consisting of ordered lamellar domains with an even spacing of 67 A. The most active cationic lipid/siRNA complexes for gene silencing were obtained with 4,5-disubstituted 2-deoxystreptamine aminoglycoside derivatives and were characterized by the siRNA being entrapped in small particles exhibiting lamellar microdomains corresponding to siRNA molecules sandwiched between the lipid bilayers. These results clearly show that lipidic aminoglycoside derivatives constitute a versatile class of siRNA nanocarriers allowing efficient gene silencing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17923669      PMCID: PMC2034216          DOI: 10.1073/pnas.0707431104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Recognition of cognate transfer RNA by the 30S ribosomal subunit.

Authors:  J M Ogle; D E Brodersen; W M Clemons ; M J Tarry; A P Carter; V Ramakrishnan
Journal:  Science       Date:  2001-05-04       Impact factor: 47.728

Review 3.  Delivery of RNA interference.

Authors:  Charles X Li; Amy Parker; Ellen Menocal; Shuanglin Xiang; Laura Borodyansky; Johannes H Fruehauf
Journal:  Cell Cycle       Date:  2006-09-15       Impact factor: 4.534

Review 4.  RNA interference as a gene-specific approach for molecular medicine.

Authors:  A Grünweller; R K Hartmann
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

5.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

6.  Kanamycin A-derived cationic lipids as vectors for gene transfection.

Authors:  Matthieu Sainlos; Michelle Hauchecorne; Noufissa Oudrhiri; Samia Zertal-Zidani; Abderrahim Aissaoui; Jean-Pierre Vigneron; Jean-Marie Lehn; Pierre Lehn
Journal:  Chembiochem       Date:  2005-06       Impact factor: 3.164

7.  Reducible cationic lipids for gene transfer.

Authors:  B Wetzer; G Byk; M Frederic; M Airiau; F Blanche; B Pitard; D Scherman
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

8.  Formulations which increase the size of lipoplexes prevent serum-associated inhibition of transfection.

Authors:  J Turek; C Dubertret; G Jaslin; K Antonakis; D Scherman; B Pitard
Journal:  J Gene Med       Date:  2000 Jan-Feb       Impact factor: 4.565

9.  Sterically stabilized BGTC-based lipoplexes: structural features and gene transfection into the mouse airways in vivo.

Authors:  B Pitard; N Oudrhiri; O Lambert; E Vivien; C Masson; B Wetzer; M Hauchecorne; D Scherman; J L Rigaud; J P Vigneron; J M Lehn; P Lehn
Journal:  J Gene Med       Date:  2001 Sep-Oct       Impact factor: 4.565

10.  Aminoglycoside-derived cationic lipids as efficient vectors for gene transfection in vitro and in vivo.

Authors:  Philippe Belmont; Abderrahim Aissaoui; Michelle Hauchecorne; Noufissa Oudrhiri; Laure Petit; Jean-Pierre Vigneron; Jean-Marie Lehn; Pierre Lehn
Journal:  J Gene Med       Date:  2002 Sep-Oct       Impact factor: 4.565

View more
  33 in total

1.  SPANosomes as delivery vehicles for small interfering RNA (siRNA).

Authors:  Chenguang Zhou; Yicheng Mao; Yasuro Sugimoto; Yue Zhang; Naveen Kanthamneni; Bo Yu; Robert W Brueggemeier; L James Lee; Robert J Lee
Journal:  Mol Pharm       Date:  2011-12-29       Impact factor: 4.939

2.  A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription.

Authors:  Indrajit Das; Jérôme Désiré; Dinesh Manvar; Isabelle Baussanne; Virendra N Pandey; Jean-Luc Décout
Journal:  J Med Chem       Date:  2012-06-22       Impact factor: 7.446

Review 3.  Strategies, design, and chemistry in siRNA delivery systems.

Authors:  Yizhou Dong; Daniel J Siegwart; Daniel G Anderson
Journal:  Adv Drug Deliv Rev       Date:  2019-05-15       Impact factor: 15.470

4.  Effect of IL-1β, TNF-α and IGF-1 on trans-endothelial passage of synthetic vectors through an in vitro vascular endothelial barrier of striated muscle.

Authors:  J P Gomez; C Gonçalves; C Pichon; P Midoux
Journal:  Gene Ther       Date:  2017-05-15       Impact factor: 5.250

5.  Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis.

Authors:  Mingzhen Zhang; Xiaoyu Wang; Moon Kwon Han; James F Collins; Didier Merlin
Journal:  Nanomedicine (Lond)       Date:  2017-06-30       Impact factor: 5.307

Review 6.  Lipid-based nanotherapeutics for siRNA delivery.

Authors:  A Schroeder; C G Levins; C Cortez; R Langer; D G Anderson
Journal:  J Intern Med       Date:  2010-01       Impact factor: 8.989

7.  1-(4-Alkyloxybenzyl)-3-methyl-1H-imidazol-3-ium organic backbone: a versatile smectogenic moiety.

Authors:  William Dobbs; Laurent Douce; Benoît Heinrich
Journal:  Beilstein J Org Chem       Date:  2009-11-06       Impact factor: 2.883

Review 8.  Nature as a source of inspiration for cationic lipid synthesis.

Authors:  Romain Labas; Fanny Beilvert; Benoit Barteau; Stéphanie David; Raphaël Chèvre; Bruno Pitard
Journal:  Genetica       Date:  2009-09-11       Impact factor: 1.082

9.  Redox-based control of the transformation and activation of siRNA complexes in extracellular environments using ferrocenyl lipids.

Authors:  Burcu S Aytar; John P E Muller; Yukishige Kondo; Yeshayahu Talmon; Nicholas L Abbott; David M Lynn
Journal:  J Am Chem Soc       Date:  2013-06-07       Impact factor: 15.419

10.  Solid polymeric microparticles enhance the delivery of siRNA to macrophages in vivo.

Authors:  Sungmun Lee; Stephen C Yang; Chen-Yu Kao; Robert H Pierce; Niren Murthy
Journal:  Nucleic Acids Res       Date:  2009-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.